Browsing: Patients

(From left) Elaine Ho, care clinician and head of community health for Loving Heart, community carer Germaine Soh and care connector Ranjit Kaur

AT A GLANCE: A brain aneurysm can be silent for years or rupture without warning. Here are four things you will learn about brain aneurysms from Yazan Alderazi, MD, a neuroendovascular surgeon, vascular neurologist and neurointensivist at HCA Healthcare, in this article:

Thomas Zordani flew from his home in Denver to Phoenix for a consultation with a Mayo Clinic neurosurgeon, hoping to find out what could be done to treat his debilitating headaches after worrisome brain scan findings

The addiction treatment field often looks at recovery as an ongoing journey, rather than a final destination. But changes to Medicaid brought on by the One Big Beautiful Bill could threaten to turn recovery milestones into an insurance cliff for patients who rely on coverage to maintain stability

There’s no shortage of weight-loss advice on social media, TikTok, television, and AI chatbots. But the most credibley’re not hearing from

A temporary federal program is helping more South Dakotans gain access to GLP-1 medications to treat obesity. Beginning in July, eligible Medicare Part D beneficiaries pay a fixed rate of $50 per month. It’s a pilot program set to end in December 2027

Lifestyle medicine is an increasingly important specialty that helps prevent and manage obesity and other chronic diseases. The foundation of lifestyle medicine is helping patients incorporate sustainable healthy habits into their everyday lives. 

AT A GLANCE: As tick activity continues to be a concern in many parts of the country, physicians say prevention starts before you go outside and continues after you come back in. Here are five key things patients will learn about tickborne illnesses from Alex Benjamin, MD, an infectious diseases physician at Jefferson Health, in…

HealthDay News — A considerable proportion of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) exhibit anxiety symptoms, according to a study published online July 23 in the Journal of Inflammation Research

Lilly and Novo cut prices as the obesity drug market races toward US$100 billion by 2030